- Phase 2 IND submission targeted for the second half of 2026 - Demonstrating the competitiveness of GC Biopharma's mRNA platform YONGIN, South Korea, Dec. 22, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a leading global biopharmaceutical company, announced today that Ministry of Food...
Hence then, the article about gc biopharma secures ind approval for phase 1 clinical trial of covid 19 mrna vaccine in korea was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( GC Biopharma Secures IND Approval for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea )
Also on site :
- Drew Barrymore’s New Stoneware Dinnerware Set Brings Sweet Vintage-Inspired Cabbageware Charm to the Table
- Ukraine-Russia war latest: Zelensky vows response to Russia’s ‘terrorist attack’ as strike on mall kills 16
- Olivia Rodrigo Releases ‘Handmaid’s Tale’-Inspired Song, ‘Serena Joy,’ in a Tiny Run of CDs, With Digital Drop to Follow